about
Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre TrialElevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.Pediatric liver diseases: current challenges and future perspectives.Docosahexaenoic Acid and Its Role in G-Protein-Coupled Receptor 120 Activation in Children Affected by Nonalcoholic Fatty Liver Disease.Beverage consumption and paediatric NAFLD.Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD).Epicardial adipose tissue and signs of metabolic syndrome in children.Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.Coeliac disease screening among a large cohort of overweight/obese children.The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis.Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD.Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease-Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production.Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?Reply to: "Energy drinks and adolescents - A hepatic health hazard?"Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study.Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.First case of nonalcoholic steatohepatitis in a child with del(1p36) and dup (Xp22): review of the literature.The relationship between body mass index and children's presentations to a tertiary pediatric emergency department.Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic InflammationA review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver diseasePortal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver diseaseThe wide spectrum of hepatic iron overloadObalon intragastric balloon in the treatment of paediatric obesity: a pilot studyObalon intragastric balloon in the treatment of paediatric obesity: a pilot studyReply to: "Fructose, uric acid and zonal differences in NASH"Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescentsPlasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease
P50
Q36225138-1FEBA9B9-4DD1-414F-B747-1FFA9E7F51B1Q38652793-0F09B6D0-90CD-4F05-A33A-25FA440F2044Q38660846-16C5C9A3-2DFF-4088-967F-F557205C4343Q38673447-A828B9ED-4956-4D6E-8362-C89BB091DFD5Q38937960-569DE5BC-689F-4AC5-9881-1294F1A74E7CQ38954264-2EA00058-D9B6-4CB3-85D0-AA35535EEEE5Q40181436-2573091E-8E91-4306-805E-86658270C4BDQ40244259-F9429449-1E08-4962-B9DF-CF3D0622992EQ40513444-EA18BCDE-50B8-4955-95EE-AEF3DA060CF7Q40706893-4C586842-3CCE-41D3-AC0F-247A5C103DD3Q44354213-306A2830-F957-409B-B10F-51356E76CFE5Q47810372-90744043-B377-4F25-A63D-A8058A189A6EQ48024919-870896A7-F51A-4B62-AC13-25BF5D6C8A99Q49339771-3A911FAD-5F6B-4D4D-A265-C8965DDF6A03Q49592407-7301B434-5D02-488F-ADE6-F7681C9D1F66Q49635019-B5C1E109-3F1E-4D5C-A663-4E707AB786E2Q50948394-6412D742-47A2-4566-B278-D1C8A2109D3FQ51265948-FA08C4A3-1324-4EAC-AEEB-C28F57D4D1E9Q52750551-4F8C1ACE-E6A6-44FD-9908-827B710F8E51Q55118693-D9DD47EC-0689-4FA4-A7BE-8A2568E55FC9Q56507689-7C0FEDFD-2D94-43DC-9649-5F2990C01F5FQ57820524-615AC4D4-B6D6-4012-BAD6-35BFF4BC6410Q62066868-25237536-2690-460B-9423-07C2C1FB837CQ62066946-673DA6BF-D676-4593-A09C-D881FA874C97Q85958630-0075FE3C-DA94-43CB-867A-AB5256711E01Q88048526-B2FD7D70-8FD4-4C96-8AC9-93F8CBDE5B9FQ88478789-AEEDD75E-6930-4F2B-A1AB-341237D7EC51Q91271241-41DC40C1-310C-4213-A147-C722E3262590Q92767147-124D84CA-42BC-4C05-9D9A-F692EC10F053
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A Mosca
@ast
A Mosca
@en
A Mosca
@es
A Mosca
@nl
A Mosca
@sl
type
label
A Mosca
@ast
A Mosca
@en
A Mosca
@es
A Mosca
@nl
A Mosca
@sl
prefLabel
A Mosca
@ast
A Mosca
@en
A Mosca
@es
A Mosca
@nl
A Mosca
@sl
P106
P1153
38461416500
P31
P496
0000-0001-9646-7462